Clinical Trial Update: Apatinib for Advanced Biliary Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for apatinib in advanced biliary tract neoplasms (biliary carcinoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Carcinoma
• Biliary Tract Neoplasms

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Fudan University | Conditions: Biliary Tract Neoplasms | Phase 2 | Status: UNKNOWN